Concepedia

Sharlene Litchy

SL

16

Publications

2.4K

Citations

15

H-Index

2000

Active since

Affiliations

Tennessee Oncology(Current)

Sarah Cannon

University of South Carolina Upstate

Northwest Behavioral Medicine

South Carolina Oncology Associates

Sharlene Litchy is an author at Tennessee Oncology specializing in cancer therapeutics, radiation oncology, and oncology.

Top concepts

Publications per year

2000–2006

16

Publications

16

Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

John D. Hainsworth, Sharlene Litchy, Howard A. Burris et al. · Journal of Clinical Oncology · 2002 · 417 citations

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

John D. Hainsworth, Sharlene Litchy, John H. Barton et al. · Journal of Clinical Oncology · 2003 · 350 citations

Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's Lymphoma—A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network

John D. Hainsworth, Sharlene Litchy, Don W. Shaffer et al. · Journal of Clinical Oncology · 2005 · 331 citations

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey et al. · Blood · 2000 · 263 citations

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey et al. · Blood · 2000 · 248 citations

Rows per page

1–5 of 16